Recommended IV Metoclopramide Dose in Children
The recommended intravenous dose of metoclopramide for children is 0.1 mg/kg per dose, with a maximum single dose of 10 mg, administered slowly over 1-2 minutes. 1
Dosing by Clinical Indication
For Facilitating Small Bowel Intubation or Radiological Examinations
- Children under 6 years: 0.1 mg/kg IV over 1-2 minutes 1
- Children 6-14 years: 2.5-5 mg IV over 1-2 minutes 1
- Children over 14 years and adults: 10 mg IV over 1-2 minutes 1
For Prevention of Chemotherapy-Induced Nausea and Vomiting
- Highly emetogenic chemotherapy (cisplatin, dacarbazine): 2 mg/kg per dose IV infused over at least 15 minutes 1
- Less emetogenic regimens: 1 mg/kg per dose IV infused over at least 15 minutes 1
- Dosing schedule: 30 minutes before chemotherapy, repeat every 2 hours for two doses, then every 3 hours for three doses 1
For Postoperative Nausea and Vomiting Prevention
Research studies have evaluated doses of 0.15-0.25 mg/kg IV for postoperative emesis prevention. The 0.25 mg/kg dose demonstrated superior efficacy compared to 0.15 mg/kg in preventing vomiting after strabismus surgery (29% vs 68% incidence) 2. Two doses of 0.25 mg/kg (one preoperative, one at 1 hour postoperatively) reduced posttonsillectomy vomiting to 18% compared to 50% with placebo 3.
Critical Administration Guidelines
Administer slowly over 1-2 minutes for standard doses to minimize cardiovascular effects, though rapid administration of 0.15-0.25 mg/kg has been shown safe in healthy children 4. For doses exceeding 10 mg, dilute in 50 mL of parenteral solution and infuse over at least 15 minutes 1.
Important Caveats and Warnings
Extrapyramidal Reactions
- Risk increases with higher doses and repeated administration 5
- Hypotension and dystonic reactions may occur 5
- If acute dystonic reactions occur, administer diphenhydramine 50 mg IM 1
- Repeated doses can prolong QT interval and precipitate torsades de pointes 5
Renal Impairment
In patients with creatinine clearance below 40 mL/min, initiate therapy at approximately one-half the recommended dosage to avoid drug accumulation 1. Metoclopramide is primarily renally excreted, and renal impairment significantly reduces clearance 1.
Age-Specific Considerations
Very young infants (under 1 month) have significantly prolonged half-life (23.1 hours in a 3.5-week-old infant vs 4.1 hours in older infants) due to immature hepatic and renal systems 1. Exercise particular caution in neonates and consider lower doses or extended dosing intervals.
Drug Accumulation Risk
Repeated dosing every 6 hours leads to drug accumulation, with peak plasma concentrations doubling after 10 doses in infants 1. This underscores the importance of limiting duration of therapy and monitoring for adverse effects with repeated administration.
Evidence Quality Note
The FDA label 1 explicitly states there are insufficient reliable data to support efficacy of metoclopramide in pediatric patients with gastroesophageal reflux or chemotherapy-induced nausea and vomiting, and pharmacodynamics are highly variable without an established concentration-effect relationship 1. Despite widespread use, pediatric dosing is largely extrapolated from adult data and limited pharmacokinetic studies rather than robust efficacy trials.